Benign neoplasm: Adrenal gland

CD2_BENIGN_ADRENAL_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D35.0& Hospital discharge: ICD-9 — 2270 Hospital discharge: ICD-8 — 2260 Cause of death: ICD-10 — D35.0& Cause of death: ICD-9 — 2270 Cause of death: ICD-8 — 2260 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D35
Name in latin: Neoplasma benignum glandulae suprarenalis

NAME	CD2_BENIGN_ADRENAL_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D350
HD_ICD_9	2270
HD_ICD_8	2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D350
COD_ICD_9	2270
COD_ICD_8	2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Adrenal gland based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Adrenal gland

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2662	1527	1135
Unadjusted period prevalence (%)	0.51	0.52	0.50
Median age at first event (years)	63.53	61.84	65.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2334: Matched controls
23340

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4503599627370496.0

323.0

2296

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

276.3

323.0

582

BC1AD

NOMESCO Finland

CT of adrenal glands

249.8

323.0

509

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

674.9

250.1

243

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

225.7

238.5

243

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

158.1

150

C61

ICD-10 Finland

Malignant neoplasm of prostate

546.6

156.7

154

E26.0

ICD-10 Finland

Primary hyperaldosteronism

48.8

141.1

172

115

Kela drug reimbursment

Breast cancer

+∞

130.4

124

130

Kela drug reimbursment

Malignant tumour

+∞

127.2

121

PJA12

NOMESCO Finland

Sentinel node biopsy

315.4

118.3

119

H02AB02

ATC

dexamethasone; systemic

17.6

101.7

163

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.2

98.9

424

1174

A04AA02

ATC

granisetron; systemic, transdermal

109.8

96.8

105

WF002

NOMESCO Finland

Radical radiotherapy

118.4

94.7

102

JN4BD

NOMESCO Finland

Extensive body CT

5.9

94.6

284

534

116

Kela drug reimbursment

Prostate cancer

+∞

83.8

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

83.7

752

3526

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

79.6

C03DA01

ATC

spironolactone; oral

3.5

79.2

415

1345

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

77.2

78.7

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

78.6

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

94.4

74.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

73.8

1144

6993

N02BE01

ATC

paracetamol; systemic, rectal

3.0

69.3

2090

17339

BCA30

NOMESCO Finland

Unilateral adrenalectomy

+∞

69.1

BC4WT

NOMESCO Finland

Selective blood sample from adrenal gland with radiological guidance

182.9

68.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

68.0

B01AB05

ATC

enoxaparin; parenteral

2.3

64.7

795

4278

A03FA01

ATC

metoclopramide; systemic, rectal

3.1

64.6

411

1517

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

63.1

326

1032

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

61.7

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

60.9

1545

11275

JN4AD

NOMESCO Finland

Body CT examination

5.8

60.1

180

333

L02BG04

ATC

letrozole; oral

23.1

60.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.3

59.6

704

3686

WZC30

NOMESCO Finland

Teaching

3.2

58.8

340

1169

WX402

NOMESCO Finland

General anaesthesia

2.9

58.4

418

1657

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

58.3

565

2672

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

57.7

901

5336

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

56.2

704

3769

HAC20

NOMESCO Finland

Total mastectomy

151.2

56.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

6.1

55.5

159

278

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

194.5

55.2

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

194.5

55.2

H02AB09

ATC

hydrocortisone; systemic

7.9

54.2

128

170

BC1BD

NOMESCO Finland

Extensive CT of adrenal glands

191.1

54.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.5

52.7

119

147

HAB40

NOMESCO Finland

Wedge excision of mammary gland

23.1

52.5

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

52.3

WF003

NOMESCO Finland

Adjuvant radiotherapy

184.1

52.1

A10BA02

ATC

metformin; oral

2.1

51.9

792

4594

E24.8

ICD-10 Finland

Other Cushing syndrome

266.2

51.3

XX3DW

NOMESCO Finland

Time consuming IT work

4.3

50.9

200

495

JN3AD

NOMESCO Finland

Abdominal CT examination

3.6

50.9

246

732

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

12.4

50.2

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

50.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

177.1

50.1

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

497.9

49.6

L03AA13

ATC

pegfilgrastim; parenteral

+∞

49.1

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

18.9

48.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.3

48.5

533

2651

L01BC06

ATC

capecitabine; oral

+∞

48.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.2

47.8

282

975

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

12.7

47.5

A02BC02

ATC

pantoprazole; systemic

1.9

47.2

1560

11952

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

47.2

501

2447

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

47.0

C07AB07

ATC

bisoprolol; oral

1.9

46.8

1227

8640

J01DB01

ATC

cefalexin; oral

2.1

46.8

1915

15904

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

46.2

305

1138

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

45.4

703

4055

UJF32

NOMESCO Finland

Coloscopy

2.1

45.2

664

3746

C08CA01

ATC

amlodipine; oral

1.9

45.0

954

6199

N02AX02

ATC

tramadol; systemic, rectal

1.9

44.5

1055

7126

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

445.7

44.4

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

43.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.6

43.4

132

248

T90

ICPC

Diabetes non-insulin dependent

2.0

42.5

653

3733

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

40.8

722

4351

NK6AN

NOMESCO Finland

Total body bone isotope imaging

35.4

40.4

E260, I152

ICD-10 Finland

208.4

40.0

L02AE02

ATC

leuprorelin; implant, parenteral

13.0

39.9

L02BA01

ATC

tamoxifen; oral

109.4

39.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.7

39.5

117

213

WX110

NOMESCO Finland

Local anesthesy

1.8

38.8

1535

12045

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

29.5

38.7

C03CA01

ATC

furosemide; systemic

1.9

36.7

677

4106

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

36.5

R4110

NOMESCO Finland

Physiotherapy

1.9

36.4

625

3690

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

35.7

721

4510

L02BB03

ATC

bicalutamide; oral

+∞

35.5

WF049

NOMESCO Finland

Radiotherapy of metastasis

352.2

35.0

ZX080

NOMESCO Finland

Image guided radiotherapy

182.6

34.8

Y77

ICPC

Malignant neoplasm prostate

125.2

34.8

ZX120

NOMESCO Finland

Intravenous

3.0

34.1

216

779

JN4CD

NOMESCO Finland

Very extensive body CT

6.9

33.7

129

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

33.4

C50.99

ICD-10 Finland

Breast, unspecified

+∞

33.4

P01AB01

ATC

metronidazole; oral, rectal

1.7

33.1

944

6563

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

32.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

32.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

9.9

32.1

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.8

31.7

164

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

31.3

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

31.3

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

316.8

30.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

30.9

399

2089

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

30.9

210

791

N07BA03

ATC

varenicline; oral

3.2

30.4

166

539

R06.0

ICD-10 Finland

Dyspnoea

1.8

30.1

602

3713

C50

ICD-10 Finland

Malignant neoplasm of breast

306.1

29.9

R03AC02

ATC

salbutamol; inhalant

1.6

29.8

1205

9163

KCD02

NOMESCO Finland

Transurethral resection of bladder

19.1

29.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

29.5

219

866

205

Kela drug reimbursment

Chronic hypertension

1.8

29.5

709

4631

ZX090

NOMESCO Finland

Other technic of radiotherapy

50.7

29.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.5

29.4

144

431

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.5

29.4

124

B01AB10

ATC

tinzaparin; parenteral

3.4

29.3

148

454

A04AA55

ATC

palonosetron, combinations; systemic

+∞

29.2

R03BB04

ATC

tiotropium bromide; inhalant

2.4

29.1

280

1278

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

29.1

726

4799

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.9

28.5

199

J01MA02

ATC

ciprofloxacin; systemic

1.7

28.4

857

5981

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

28.2

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

28.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

28.2

N02AA05

ATC

oxycodone; systemic

2.3

28.0

287

1347

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

27.9

858

6011

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.6

27.9

100

226

N03AX16

ATC

pregabalin; oral

1.8

27.9

570

3525

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

101.2

27.7

A04AA01

ATC

ondansetron; systemic, rectal

4.5

27.7

100

228

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

27.3

303

1476

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

38.3

27.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

27.1

474

2777

S18

ICPC

Laceration/cut

1.6

26.9

938

6783

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

274.0

26.8

UKC02

NOMESCO Finland

Cystoscopy

2.0

26.6

356

1883

C02AC05

ATC

moxonidine; oral

3.0

26.1

155

533

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

26.1

HA1AA

NOMESCO Finland

X-ray mammography

3.9

25.8

109

289

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

20.3

25.6

Z51.5

ICD-10 Finland

Palliative care

5.4

25.5

149

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.3

25.4

133

419

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

25.2

134

427

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

25.0

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

25.0

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

25.0

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

17.2

24.9

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.3

24.6

129

407

L03AA02

ATC

filgrastim; parenteral

34.9

24.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

24.0

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

24.0

H02AB06

ATC

prednisolone; systemic

1.6

23.9

1059

8062

SPAT1262

SPAT

Handing over of treatment supplies

1.8

23.8

446

2663

J01MA12

ATC

levofloxacin; systemic

1.9

23.7

400

2299

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

87.6

23.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

23.4

217

967

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

8.4

23.1

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

22.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

22.9

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

22.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

22.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

22.9

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

22.9

2270A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Adrenal gland

+∞

22.9

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

22.7

267

1332

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

84.2

22.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

232.1

22.6

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

22.5

259

1281

E87.6

ICD-10 Finland

Hypokalaemia

3.6

22.4

104

299

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

22.3

397

2321

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

22.2

196

851

XW000

NOMESCO Finland

Bone marrow biopsy

3.9

22.2

240

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

22.0

400

2358

ZXC96

NOMESCO Finland

Robot assisted procedure

11.3

21.9

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

21.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

21.9

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

39.0

21.7

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

39.0

21.7

A10BH01

ATC

sitagliptin; oral

2.1

21.6

263

1330

N06AX16

ATC

venlafaxine; oral

2.0

21.4

299

1600

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

21.3

162

651

J01FF01

ATC

clindamycin; systemic

1.6

20.8

611

4148

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

20.7

218

1034

X76

ICPC

Malignant neoplasm breast female

211.7

20.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

111.0

20.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

20.5

390

2330

A02BC05

ATC

esomeprazole; systemic

1.5

20.4

937

7104

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.2

20.4

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

32.8

20.2

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

48.4

20.2

N06AX11

ATC

mirtazapine; oral

1.6

19.9

710

5063

XKD00

NOMESCO Finland

Uroflowmetry

1.9

19.9

311

1733

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

19.8

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

19.7

224

1097

WF004

NOMESCO Finland

Palliative radiotherapy

74.1

19.7

ZX070

NOMESCO Finland

Intensity modified radiotherapy

74.1

19.7

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

12.2

19.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

19.5

1033

8059

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

19.4

373

2229

E66.8

ICD-10 Finland

Other obesity

2.6

19.4

143

566

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.4

18.8

287

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

18.8

Z71.8

ICD-10 Finland

Other specified counselling

1.7

18.7

491

3223

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

18.7

146

596

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

18.7

467

3024

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

18.7

137

538

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

9.4

18.6

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

100.8

18.6

A04AD12

ATC

aprepitant; systemic

100.8

18.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

18.6

1062

8393

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

191.4

18.5

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

191.4

18.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.8

18.4

133

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

7.5

18.4

R31

ICD-10 Finland

Unspecified haematuria

2.1

18.3

210

1035

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

18.2

123

460

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

18.1

271

1482

WX892

NOMESCO Finland

Monitored bed care

2.2

18.1

185

866

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

17.8

157

682

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

17.8

862

6555

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

17.7

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

17.7

N28.1

ICD-10 Finland

Cyst of kidney

5.2

17.6

105

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

95.7

17.6

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

17.4

273

1518

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

5.9

17.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

17.0

137

567

G47.3

ICD-10 Finland

Sleep apnoea

1.6

16.9

503

3403

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.2

16.9

155

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

16.8

495

3338

Z72.0

ICD-10 Finland

Tobacco use

3.5

16.8

226

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.5

16.8

133

L02BG03

ATC

anastrozole; oral

63.8

16.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

16.7

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

16.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

16.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

16.7

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

16.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

16.7

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

16.7

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

+∞

16.7

C10AA01

ATC

simvastatin; oral

1.5

16.7

1027

8174

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

16.6

225

1185

ZXA00

NOMESCO Finland

Right side

1.6

16.6

589

4161

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

16.6

132

545

2533

FHL

Unilateral removal of additional egg

171.1

16.5

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

40.3

16.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

16.2

324

1955

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

16.1

402

2593

WW500

NOMESCO Finland

Blood transfusion

3.9

16.0

173

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

15.7

119

477

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

+∞

15.6

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

15.6

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

15.6

A46

ICD-10 Finland

Erysipelas

1.8

15.5

307

1846

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

15.3

478

3263

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

15.3

555

3925

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

15.3

284

1671

A02BA02

ATC

ranitidine; systemic

1.6

15.3

442

2961

WX002

NOMESCO Finland

Sedation and analgesia

1.6

15.2

434

2897

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

15.1

279

1640

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

15.1

110

433

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

15.1

155

728

R10.0

ICD-10 Finland

Acute abdomen

3.0

15.0

290

SPAT1254

SPAT

Administration of medicine

1.7

15.0

306

1855

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

15.0

499

3458

N05CF01

ATC

zopiclone; oral

1.5

15.0

690

5147

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

31.9

14.8

D35.9

ICD-10 Finland

Benign neoplasm: Endocrine gland, unspecified

57.0

14.8

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.3

14.7

229

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

14.7

106

414

D01

ICPC

Abdominal pain/cramps general

1.9

14.6

227

1258

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

14.6

139

628

ZZR00

NOMESCO Finland

Flap of skin

7.8

14.6

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

14.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

14.6

GDC00

NOMESCO Finland

Lobectomy of lung

80.6

14.6

WX704

NOMESCO Finland

Intubation

2.2

14.6

151

711

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

14.5

253

1461

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

14.3

270

1595

C10AA05

ATC

atorvastatin; oral

1.4

14.3

901

7134

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.2

397

2631

C09CA03

ATC

valsartan; oral

1.9

14.2

223

1240

N03AX12

ATC

gabapentin; oral

1.7

14.2

355

2284

R50.9

ICD-10 Finland

Fever, unspecified

1.8

14.0

248

1438

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

13.9

640

4758

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

13.9

464

3210

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

15.8

13.9

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

13.9

158

775

R02

ICPC

Shortness of breath/dyspnoea

1.7

13.8

276

1663

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

13.7

306

1904

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.1

13.7

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

13.7

270

C09CA01

ATC

losartan; oral

1.5

13.6

554

4005

WX290

NOMESCO Finland

Other blockade of nerve

1.4

13.6

839

6602

N05BA04

ATC

oxazepam; oral

1.5

13.6

513

3652

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

75.5

13.6

D70.82

ICD-10 Finland

Drug-induced neutropenia

12.1

13.6

M54.5

ICD-10 Finland

Low back pain

1.5

13.6

675

5092

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

13.6

234

1344

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

13.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

13.5

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

13.5

468

3263

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

13.5

115

491

N06AX21

ATC

duloxetine; oral

1.8

13.5

232

1329

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.3

13.5

124

553

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

140.7

13.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

13.4

372

2457

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.2

13.3

A06AD11

ATC

lactulose; oral

1.7

13.3

268

1619

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

13.3

251

1486

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

13.3

347

TQW20

NOMESCO Finland

Tatoe

40.3

13.1

A79

ICPC

Malignancy NOS

40.3

13.1

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.6

13.1

163

R60.0

ICD-10 Finland

Localized oedema

1.8

13.0

250

1484

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

12.9

236

1382

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

50.3

12.8

SPAT1153

SPAT

Removal of sutures

1.4

12.8

660

5003

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

12.7

194

XJH00

NOMESCO Finland

Transanal ultrasonography

2.3

12.7

116

516

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.9

12.6

194

1071

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

12.6

379

2552

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

70.2

12.6

KAC10

NOMESCO Finland

Total nephrectomy with capsule

70.2

12.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

70.2

12.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

70.2

12.6

R4190

NOMESCO Finland

Nutritional therapy

3.2

12.6

212

S10

ICPC

Boil/carbuncle

2.2

12.6

128

599

207

Kela drug reimbursment

Chronic arrhythmias

1.6

12.6

321

2073

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

11.0

12.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

12.5

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

+∞

12.5

1CD02

NOMESCO Finland

+∞

12.5

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

+∞

12.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

12.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

12.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.3

12.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

12.4

154

782

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

12.4

358

2383

J01AA02

ATC

doxycycline; systemic

1.4

12.4

1743

15734

C08CA02

ATC

felodipine; oral

1.8

12.3

215

1240

K30

ICD-10 Finland

Functional dyspepsia

1.8

12.3

237

1413

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

8.5

12.3

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

4.2

12.2

108

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

37.7

12.2

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

6.7

12.2

N06AB04

ATC

citalopram; systemic

1.5

12.2

466

3318

ZXA05

NOMESCO Finland

Left side

1.5

12.1

524

3830

N06AB10

ATC

escitalopram; oral

1.6

12.1

374

2535

S77

ICPC

Malignant neoplasm of skin

21.4

12.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

11.9

161

848

C08CA13

ATC

lercanidipine; oral

1.6

11.9

317

2067

R04.2

ICD-10 Finland

Haemoptysis

2.8

11.9

279

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

11.9

592

4448

D06

ICPC

Abdominal pain localized other

1.9

11.9

170

913

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

11.9

486

3505

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

11.8

158

828

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

11.8

102

443

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

14.7

11.8

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.5

11.8

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

11.7

311

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

65.2

11.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

11.6

548

4069

EBA00

NOMESCO Finland

Extraction of tooth

1.4

11.6

661

5091

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

11.5

154

808

B01AC04

ATC

clopidogrel; oral

1.6

11.5

360

2444

KH1AD

NOMESCO Finland

CT of urinary organs

2.8

11.5

273

A10AE04

ATC

insulin glargine; parenteral

1.8

11.5

208

1214

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

11.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

11.5

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

11.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

11.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

11.5

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

11.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

11.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

11.5

L02BX02

ATC

degarelix; parenteral

+∞

11.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

11.5

A28

ICPC

Limited function/disability NOS

1.6

11.5

299

1939

M48.0

ICD-10 Finland

Spinal stenosis

1.6

11.4

285

1823

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.9

11.4

120

M04AA01

ATC

allopurinol; systemic

1.7

11.2

252

1570

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

11.2

113

526

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.5

11.2

363

A10BK01

ATC

dapagliflozin; oral

2.2

11.2

113

528

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

11.1

262

1651

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

11.1

456

3290

A02BC01

ATC

omeprazole; systemic

1.4

11.1

572

4318

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

11.0

207

1222

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

3.2

11.0

177

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

9.2

11.0

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

11.0

1145

9731

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

11.0

810

6512

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.1

10.9

189

K92.1

ICD-10 Finland

Melaena

2.3

10.9

104

473

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

10.9

141

732

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.4

10.9

382

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.4

10.9

157

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

10.8

158

A10BK03

ATC

empagliflozin; oral

1.9

10.8

167

924

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

10.7

120

587

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

10.7

318

2129

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.7

10.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

10.6

444

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

12.9

10.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

60.2

10.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

10.6

142

744

ZX112

NOMESCO Finland

Subcutaneous

5.3

10.6

R53

ICD-10 Finland

Malaise and fatigue

1.5

10.6

396

2800

M79.6

ICD-10 Finland

Pain in limb

1.4

10.5

758

6062

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

10.5

292

1926

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.8

10.5

115

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

110.4

10.4

L02BG06

ATC

exemestane; oral

+∞

10.4

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

10.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

10.4

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

+∞

10.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

10.4

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

10.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

10.4

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

10.4

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

10.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

10.4

XX1XN

NOMESCO Finland

Other isotope examination

+∞

10.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

10.4

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

5.6

10.4

N05AH04

ATC

quetiapine; oral

1.6

10.3

305

2038

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

32.6

10.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

10.3

230

1429

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

10.3

269

1745

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

6.1

10.3

RD211

NOMESCO Finland

2.2

10.2

453

M01AB05

ATC

diclofenac; systemic, rectal

1.3

10.2

1461

12961

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

10.2

231

1441

AA1AD

NOMESCO Finland

CT of head and brain

1.4

10.2

501

3739

JAH00

NOMESCO Finland

Laparotomy

3.1

10.2

171

Z31.5

ICD-10 Finland

Genetic counselling

2.6

10.1

276

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

10.0

159

888

A02BC03

ATC

lansoprazole; oral

1.4

10.0

636

4970

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

5.1

10.0

E23.00

ICD-10 Finland

Panhypopituitarism

7.2

10.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

40.2

10.0

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.6

9.9

271

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.9

1116

9534

J01DA01

ATC

[U] cefalexin; systemic

1.3

9.9

1306

11424

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.9

9.9

101

SPAT1263

SPAT

Sampling

1.3

9.9

862

7091

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

9.8

144

781

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

6.3

9.8

101

Kela drug reimbursment

Anterior pituitary hypofunction

6.3

9.8

JN6AD

NOMESCO Finland

CT of torso and neck

8.1

9.8

A10BJ02

ATC

liraglutide; parenteral

2.6

9.8

258

R95

ICPC

Chron obstructive pulmonary disease

2.6

9.8

283

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.3

9.8

370

A01

ICPC

Pain general/multiple sites

1.8

9.7

166

952

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

9.7

198

1198

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

7.4

9.7

A12BA01

ATC

potassium chloride; oral

2.2

9.7

439

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.2

9.6

461

C90.0

ICD-10 Finland

Multiple myeloma

55.2

9.6

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.3

9.6

146

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

6.0

9.5

J20

ICD-10 Finland

Acute bronchitis

1.7

9.5

201

1230

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.3

9.4

142

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

100.4

9.4

E27.0

ICD-10 Finland

Other adrenocortical overactivity

100.4

9.4

H01CB03

ATC

lanreotide; parenteral

100.4

9.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

100.4

9.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

100.4

9.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

9.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

9.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

9.4

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

9.4

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

9.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

9.4

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

8.1

9.3

L86

ICPC

Back syndrome with radiating pain

1.9

9.3

126

664

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

9.3

138

753

M03BX02

ATC

tizanidine; oral

1.3

9.2

1321

11631

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

9.2

234

N05CF02

ATC

zolpidem; oral

1.5

9.2

351

2487

N06AA09

ATC

amitriptyline; systemic

1.6

9.2

227

1451

A10BH05

ATC

linagliptin; oral

2.1

9.2

108

539

J01FA06

ATC

roxithromycin; oral

1.3

9.2

833

6872

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

9.1

169

993

R51.80

ICD-10 Finland

Headache

1.6

9.1

265

1767

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.2

9.0

147

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

9.0

388

2816

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

9.0

219

1393

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.0

1409

12542

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.9

9.0

180

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

9.0

603

4743

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

9.0

274

1845

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

9.0

150

855

E66

ICD-10 Finland

Obesity

2.1

8.9

445

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

8.9

167

988

B01AB04

ATC

dalteparin; parenteral

2.2

8.9

436

BAA60

NOMESCO Finland

Total thyroidectomy

3.1

8.9

155

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

8.9

968

8189

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

8.9

283

1928

L28

ICPC

Limited function/disability (L)

1.5

8.8

318

2225

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.7

8.8

102

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

8.8

1943

18191

C09DA01

ATC

losartan and diuretics; oral

1.6

8.8

235

1533

C07AB02

ATC

metoprolol; systemic

1.4

8.8

430

3199

J01EA01

ATC

trimethoprim; systemic

1.4

8.8

468

3536

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

8.7

480

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.7

8.7

C09AA02

ATC

enalapril; systemic

1.4

8.7

419

3107

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

50.1

8.7

B01AA03

ATC

warfarin; systemic

1.4

8.7

391

2861

A03

ICPC

Fever

1.6

8.7

259

1735

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.5

8.7

114

J01CA04

ATC

amoxicillin; systemic

1.3

8.7

1679

15363

WVA20

NOMESCO Finland

Medicine administration

3.2

8.7

141

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

7.6

8.6

A98

ICPC

Health maint/preventive medicine

1.7

8.6

2203

21206

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.6

8.6

AN1

Coronary angiography

1.5

8.6

258

1733

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.5

8.5

265

JFF23

NOMESCO Finland

Transversostomy

10.1

8.5

JAH01

NOMESCO Finland

Laparoscopy

2.2

8.5

398

XG466

NOMESCO Finland

Sleep oxymetry

2.2

8.5

378

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.1

8.4

425

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

8.4

291

2015

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.8

8.4

184

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

90.3

8.4

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

90.3

8.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

8.4

476

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

8.4

156

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.0

8.4

156

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

8.4

121

658

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.5

8.4

107

E26

ICD-10 Finland

Hyperaldosteronism

+∞

8.3

L02AE04

ATC

triptorelin; parenteral

+∞

8.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

8.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

8.3

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

8.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

8.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

8.3

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

8.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

8.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

8.3

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

8.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

8.3

151

-1

NOMESCO Finland

1.3

8.3

621

4954

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

8.3

274

1880

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

8.3

493

3791

L03

ICPC

Low back symptom/complaint

1.4

8.3

483

3703

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.5

8.2

103

Z01.7

ICD-10 Finland

Laboratory examination

1.6

8.2

228

1501

J01FA15

ATC

telithromycin; oral

1.6

8.2

203

1299

ZXC86

NOMESCO Finland

Use of endoscopic device

6.0

8.1

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

8.1

128

713

G04CA02

ATC

tamsulosin; oral

1.4

8.1

398

2960

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.7

8.1

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

17.2

8.1

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

17.2

8.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.3

8.1

121

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.0

8.0

100

514

A10BJ06

ATC

semaglutide; parenteral

2.2

8.0

367

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

8.0

203

1307

ZZA00

NOMESCO Finland

Split skin graft

2.8

8.0

172

D11

ICPC

Diarrhoea

1.6

8.0

190

1199

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

22.1

8.0

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

8.0

1046

9028

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.8

8.0

167

N05BA01

ATC

diazepam; systemic, rectal

1.5

7.9

268

1848

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.2

7.9

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.0

7.9

154

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

7.9

512

ZZR10

NOMESCO Finland

Flap of skin and muscle

13.1

7.9

C03AA03

ATC

hydrochlorothiazide; oral

1.6

7.9

204

1318

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

7.8

7.9

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.8

7.9

D02

ICPC

Abdominal pain epigastric

1.9

7.8

120

663

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

6.1

7.8

A08

ICPC

Swelling

2.1

7.8

439

J01FA10

ATC

azithromycin; systemic

1.3

7.8

1139

9957

N06AX12

ATC

bupropion; oral

2.0

7.8

100

520

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

7.8

470

3618

L17

ICPC

Foot/toe symptom/complaint

1.4

7.8

522

4091

J01FA01

ATC

erythromycin; systemic

1.5

7.8

236

1590

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

7.7

212

1393

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

45.1

7.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

15.1

7.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

7.7

188

1197

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

7.4

7.7

M01AB55

ATC

diclofenac, combinations; oral

1.7

7.7

149

891

B01AF02

ATC

apixaban; oral

1.6

7.7

199

1290

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

7.6

211

1388

C09BA02

ATC

enalapril and diuretics; systemic

1.6

7.6

186

1184

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.7

7.6

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

25.1

7.6

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.0

7.6

133

C09DA03

ATC

valsartan and diuretics; oral

1.9

7.6

110

598

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

7.6

286

2021

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

80.3

7.4

L04AX04

ATC

lenalidomide; oral

80.3

7.4

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

80.3

7.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

7.4

269

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

7.4

143

853

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

7.4

564

4506

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

7.4

107

583

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

6.0

7.4

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

7.3

446

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

7.3

811

6822

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

7.3

741

6157

P17

ICPC

Tobacco abuse

3.3

7.3

103

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

8.4

7.3

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

7.3

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

+∞

7.3

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

7.3

L01AX03

ATC

temozolomide; systemic

+∞

7.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

7.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

7.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

7.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

7.3

PJW99

NOMESCO Finland

Other operation on lymphatic system

+∞

7.3

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

7.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

7.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

7.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.3

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

7.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

7.3

L02BX03

ATC

abiraterone; oral

+∞

7.3

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

7.3

1423

12856

H02AB07

ATC

prednisone; oral

1.5

7.3

281

1992

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

7.3

237

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

7.3

147

S29

ICPC

Skin symptom/complaint other

1.4

7.3

316

2296

R11

ICD-10 Finland

Nausea and vomiting

1.7

7.2

135

798

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

7.2

202

1330

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

7.2

415

M01AH05

ATC

etoricoxib; oral

1.3

7.2

1252

11140

JFB46

NOMESCO Finland

Resection of sigmoid colon

4.3

7.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

7.2

129

755

153

Kela drug reimbursment

Lenalidomid

30.1

7.1

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

30.1

7.1

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.9

7.1

142

I11

ICD-10 Finland

Hypertensive heart disease

5.0

7.1

358

Kela drug reimbursment

liraglutide

4.5

7.1

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

7.1

112

630

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

7.1

373

2804

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.6

7.1

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

7.1

100

539

R52.0

ICD-10 Finland

Acute pain

2.4

7.0

225

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

10.0

7.0

C10AC01

ATC

colestyramine; oral

2.3

7.0

257

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

7.0

162

Kela drug reimbursment

liraglutide

3.0

7.0

124

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.5

7.0

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.9

7.0

139

T92

ICPC

Gout

2.7

7.0

159

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

6.9

101

549

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

6.9

174

1118

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

6.9

382

2895

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

6.9

128

757

JFB00

NOMESCO Finland

Partial resection of small intestine

3.6

6.9

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

6.9

222

C10AA07

ATC

rosuvastatin; oral

1.3

6.8

543

4356

105

Kela drug reimbursment

Adrenal cortical hypofunction

8.3

6.8

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

6.8

129

767

A10BX07

ATC

[U] liraglutide; parenteral

2.8

6.8

143

N20.1

ICD-10 Finland

Calculus of ureter

2.0

6.8

382

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.5

6.8

209

KEB00

NOMESCO Finland

Biopsy of prostate

6.1

6.8

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.8

463

3633

K86.2

ICD-10 Finland

Cyst of pancreas

3.7

6.8

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

40.1

6.8

D35.30

ICD-10 Finland

Craniopharyngoma

40.1

6.8

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

40.1

6.8

S06.0

ICD-10 Finland

Concussion

1.6

6.7

186

1222

XX1AD

NOMESCO Finland

Other CT-examination

16.7

6.7

X57

ICD-10 Finland

Unspecified privation

2.6

6.7

184

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

6.7

412

R52.9

ICD-10 Finland

Pain, unspecified

1.6

6.7

161

1023

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.7

275

1971

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

6.7

386

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

7.2

6.7

N30.0

ICD-10 Finland

Acute cystitis

1.5

6.7

253

1784

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.9

6.7

128

RD210

NOMESCO Finland

2.8

6.7

145

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

6.7

231

JLC10

NOMESCO Finland

Distal pancreatectomy

22.6

6.7

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

22.6

6.7

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

6.7

513

4098

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

5.2

6.6

M25.5

ICD-10 Finland

Pain in joint

1.3

6.6

564

4570

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

7.8

6.6

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

6.6

354

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.2

6.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

6.6

188

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

6.6

365

2765

A10BB12

ATC

glimepiride; oral

1.6

6.6

144

894

KAD00

NOMESCO Finland

Partial nephrectomy

12.3

6.6

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

12.3

6.6

R33

ICD-10 Finland

Retention of urine

1.7

6.6

129

777

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.6

460

3620

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

6.5

102

572

160

Kela drug reimbursment

exenatide

2.4

6.5

227

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.4

6.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

6.5

328

2443

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

6.5

375

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

6.5

248

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.1

6.5

A07AA02

ATC

nystatin; oral

1.7

6.5

116

679

H01

ICPC

Ear pain/earache

1.5

6.5

189

1259

N06AB06

ATC

sertraline; oral

1.5

6.5

192

1286

J01DA06

ATC

[U] cefuroxime; systemic

1.4

6.5

276

1995

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.2

6.5

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

6.2

6.5

R03AC18

ATC

indacaterol; inhalant

4.5

6.5

A04

ICPC

Weakness/tiredness general

1.5

6.5

228

1588

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

6.4

420

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

70.0

6.4

D75

ICPC

Malignant neoplasm colon/rectum

70.0

6.4

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

70.0

6.4

C08CA10

ATC

nilvadipine; oral

2.4

6.4

211

SPAT1059

SPAT

Spirometry at the office

1.7

6.4

115

673

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

6.4

450

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

6.4

115

675

XX9XW

NOMESCO Finland

4.9

6.3

PDQ05

NOMESCO Finland

Insertion of endovascular graft into infrarenal abdominal aorta

4.4

6.3

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.2

6.3

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

6.6

6.3

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.0

6.3

415

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

11.0

6.3

U04

ICPC

Incontinence urine

1.9

6.3

431

S21

ICPC

Skin texture symptom/complaint

1.5

6.3

226

1581

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

4.0

6.3

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.1

6.3

ZX050

NOMESCO Finland

Stereotactic radiotherapy

18.1

6.3

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

18.1

6.3

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

6.3

447

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

6.3

355

2698

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

6.2

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

6.2

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

6.2

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

6.2

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

6.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.2

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

6.2

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.2

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.2

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

6.2

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

6.2

D350, E260

ICD-10 Finland

+∞

6.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.2

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

6.2

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.2

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

6.2

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

6.2

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

6.2

L01CA04

ATC

vinorelbine; systemic

+∞

6.2

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

6.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

6.2

D44.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Parathyroid gland

+∞

6.2

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

6.2

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

6.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

6.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

6.2

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

6.2

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

6.2

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

6.2

E260, D350

ICD-10 Finland

+∞

6.2

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

6.2

117

693

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.5

6.2

182

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

26.7

6.2

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

6.2

369

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.2

430

3376

M01AX17

ATC

nimesulide; oral

1.3

6.2

523

4227

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

6.2

514

C07AA05

ATC

propranolol; systemic

1.4

6.1

356

2717

M01AC06

ATC

meloxicam; systemic, rectal

1.3

6.1

771

6556

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

6.1

328

2472

C09AA05

ATC

ramipril; oral

1.3

6.1

496

3985

M05BX04

ATC

denosumab; parenteral

2.0

6.1

387

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.7

6.1

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

7.7

6.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.7

6.1

136

B82

ICPC

Anaemia other/unspecified

2.4

6.1

204

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.1

6.1

102

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.1

6.1

302

C09CA07

ATC

telmisartan; oral

1.6

6.1

147

938

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.5

6.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

6.1

159

1034

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

6.1

237

U05

ICPC

Urination problems other

1.9

6.0

482

R4140

NOMESCO Finland

Psychotherapy

6.7

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

848

232

53.17

307.65

1.4

1.3

251.0

314.0

pmol/l

2.03

746

177

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

899

223

60.36

307.65

1.4

1.3

—

nmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

392

59.53

307.65

1.8

4.7

4.1

nmol/l

0.11

343

(3011985) Renin [Units/volume] in Plasma

885

250

52.53

307.65

1.4

59.9

66.7

mu/l

0.17

834

220

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

930

236

60.03

307.65

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

328

174

21.36

307.65

1.7

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1017

261

62.44

307.65

1.4

1.3

0.1

0.4

nmol/l

1.37

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1010

257

62.72

307.65

1.4

1.3

0.6

nmol/l

0.05

985

243

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

216

57.25

307.65

1.3

1.0

266.3

252.2

pmol/l

0.12

157

(37021550) Renin [Units/volume] in Plasma --upright

194

54.99

307.65

1.3

1.2

63.2

70.2

mu/l

0.08

142

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1115

1842

9.70

307.65

2.3

1.8

239.4

365.6

nmol/l

45.98

1020

1673

(4035726)

385

664

6.61

218.78

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1831

10420

3.43

191.02

6.5

3.9

10.2

11.6

umol/l

10.74

1765

9739

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

459

1129

4.70

174.19

3.6

1.4

31.8

14.8

ug/l

0.39

385

839

(3033923) Metanephrine [Moles/time] in 24 hour Urine

115

23.99

160.08

1.3

1.2

0.8

0.7

umol/24h

0.31

(3024561) Albumin [Mass/volume] in Serum or Plasma

1550

8887

2.78

142.65

5.6

3.9

34.9

35.8

g/l

9.18

1476

8163

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1740

10721

2.80

136.60

8.6

5.7

1.2

mmol/l

2.25

1523

9029

(3032080) INR in Blood by Coagulation assay

1507

8718

2.68

132.92

9.3

9.6

1.2

1.3

inr

3.54

477

2473

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2299

16738

3.74

128.69

9.3

5.5

80.9

76.1

u/l

5.85

2235

15482

(3013650) Neutrophils [#/volume] in Blood by Automated count

1811

11774

2.68

120.97

9.4

6.5

4.7

4.2

e9/l

10.65

1583

10122

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1534

9262

2.55

118.95

4.8

3.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1915

12880

2.73

117.89

6.2

4.3

7.0

6.8

mmol/l

5.68

1839

12014

(3023368) Bacteria identified in Blood by Culture

1040

5267

2.60

116.83

4.6

3.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1571

9676

2.52

115.38

7.5

5.3

1.2

mmol/l

1.69

1480

8586

(3044640) Blood type and Crossmatch panel - Blood

1097

5965

2.43

102.72

3.0

2.1

—

(3002256) Pathology report gross observation

484

1759

3.14

100.60

1.3

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

962

5097

2.39

93.63

4.3

3.5

92.4

89.2

3.23

931

4960

(3014576) Chloride [Moles/volume] in Serum or Plasma

592

2527

2.73

90.82

7.0

6.5

104.4

104.2

mmol/l

0.40

578

2467

(3012095) Magnesium [Moles/volume] in Serum or Plasma

675

3095

2.58

89.45

3.1

2.5

0.8

mmol/l

1.32

636

2844

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1162

6800

2.26

88.23

3.0

2.3

57.8

58.6

u/l

0.15

1103

6225

(3002582) Erythrocytes [#/volume] in Urine

1094

6249

2.27

88.05

3.8

3.0

162.6

73.9

e6/l

0.38

855

4721

(3026782) Osmolality of Urine

793

3957

2.43

87.29

3.0

2.6

551.1

542.8

mosm/kgh2o

0.46

700

3293

(40768804) Tissue Pathology biopsy report

1227

7389

2.23

86.28

2.4

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1026

5765

2.27

85.30

3.6

2.9

0.5

0.4

e6/l

0.22

796

4277

(3022096) Basophils/100 leukocytes in Blood

1472

9610

2.19

83.53

6.6

5.8

0.6

0.7

4.54

1386

8861

(3006504) Eosinophils/100 leukocytes in Blood

1503

9897

2.19

83.39

6.7

5.7

2.5

3.0

12.08

1421

9121

(3019069) Monocytes/100 leukocytes in Blood

1506

9939

2.19

82.89

7.1

6.0

8.4

8.7

2.81

1421

9202

(3002030) Lymphocytes/100 leukocytes in Blood

1527

10160

2.18

81.95

6.9

5.8

25.7

28.1

13.15

1439

9354

(3018095) Leukocytes [#/volume] in Urine

1219

7440

2.18

81.54

4.4

3.5

155.5

106.4

e6/l

0.48

906

5145

(3031040) Bacteria [#/volume] in Urine by Automated count

1928

14141

2.32

80.30

5.5

4.3

294.8

1906.4

e6/l

1.90

187

(3018418) pH of Serum or Plasma

1072

6255

2.20

79.99

4.7

3.4

7.4

0.92

217

1072

(3018010) Neutrophils/100 leukocytes in Blood

1509

10082

2.15

78.97

6.7

5.6

59.6

57.2

12.64

1430

9327

(3001604) Monocytes [#/volume] in Blood

1572

10690

2.15

78.29

6.2

5.5

0.6

e9/l

8.45

1342

9189

(3006315) Basophils [#/volume] in Blood

1578

10760

2.15

77.85

6.2

5.5

0.0

e9/l

2.06

1357

9251

(3019198) Lymphocytes [#/volume] in Blood

1600

10968

2.15

77.85

6.4

5.6

2.0

1.9

e9/l

1.13

1405

9602

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

540

2362

2.61

77.75

7.5

7.0

5.3

5.1

kpa

3.99

527

2253

(3027801) Oxygen [Partial pressure] in Arterial blood

538

2362

2.60

76.79

7.5

7.0

11.7

11.8

kpa

0.32

522

2253

(3013115) Eosinophils [#/volume] in Blood

1614

11145

2.14

76.46

6.6

5.6

0.2

e9/l

1.40

1411

9745

(3003396) Base excess in Arterial blood by calculation

532

2338

2.59

75.68

7.6

7.0

1.2

mmol/l

0.03

445

1806

(36304419) Bacteria [Presence] in Urine

974

5595

2.17

74.39

3.6

2.9

—

(42870588) Differential panel, method unspecified - Blood

1159

7118

2.11

74.32

6.3

5.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1123

6829

2.11

73.79

3.1

2.7

34.8

36.4

u/l

0.13

1069

6453

(3016502) Oxygen saturation in Arterial blood

490

2116

2.61

71.97

7.8

7.3

95.4

95.3

0.07

480

2033

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

410

1625

2.80

71.29

2.1

0.2

g/l

3.08

384

1479

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

837

4617

2.19

70.06

3.0

2.1

—

(3026008) Bacteria identified in Urine by Culture

1060

6414

2.08

69.53

3.5

3.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

176

414

4.48

68.84

3.1

1.9

243.2

78.9

u/ml

0.42

150

334

(3021589) Normoblasts [#/volume] in Blood

1413

9530

2.03

68.23

11.3

8.3

0.0

e9/l

0.48

1175

7760

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

490

2199

2.51

65.94

2.7

2.3

5.8

7.4

umol/l

2.03

408

1887

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

639

3228

2.29

65.80

3.2

2.7

3.0

2.8

e6/l

0.23

367

1715

(3003458) Phosphate [Moles/volume] in Serum or Plasma

560

2674

2.39

65.72

5.7

5.6

1.0

mmol/l

0.21

520

2463

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

577

2800

2.35

65.21

2.8

2.7

19.8

23.5

7.83

499

2368

(3004789) Transferrin [Mass/volume] in Serum or Plasma

604

3028

2.29

63.02

2.7

2.6

2.4

2.3

g/l

1.72

568

2808

(3002173) Hemoglobin [Mass/volume] in Arterial blood

439

1943

2.51

60.47

8.1

7.7

122.5

122.2

g/l

0.09

428

1865

(3022948) Iron [Moles/volume] in Serum or Plasma

635

3314

2.20

59.69

2.7

2.6

11.9

13.4

umol/l

5.77

601

3061

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

295

1074

2.96

59.53

8.9

9.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

420

1847

2.51

58.53

2.7

2.2

31.9

38.1

u/l

1.26

377

1547

(3037467) Urinalysis macro (dipstick) panel - Urine

1947

15150

2.06

58.12

5.2

4.2

—

(3000991) Gas panel - Venous blood

385

1650

2.56

56.53

8.6

8.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

16.48

55.63

1.2

2.1

1.8

umol/24h

0.79

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

436

2001

2.41

55.13

3.6

3.1

236.6

234.8

u/l

0.10

407

1874

(3000850) Epithelial cells [#/volume] in Urine

760

4369

2.04

54.70

2.8

2.4

6.6

5.5

e6/l

1.31

673

3768

(3042936) Bacteria identified in Isolate by Culture

559

2878

2.19

53.73

2.3

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2523

22185

3.63

53.27

21.9

12.4

25.1

22.5

mg/l

3.75

2269

17108

(3036603) Volume of Urine

124

6.79

51.90

1.5

1.4

1797.0

2151.6

0.54

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

274

1031

2.85

51.82

8.3

9.5

24.2

24.4

mmol/l

0.24

261

951

(40758558) Short blood count panel - Blood

826

4994

1.95

50.78

6.5

4.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

646

3583

2.06

50.76

3.1

2.6

1.1

1.2

e6/l

0.22

374

2058

(3013707) Erythrocyte sedimentation rate by Westergren method

2080

16910

2.05

50.37

4.9

4.1

14.9

11.8

mm/h

15.12

1964

15629

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

869

5361

1.92

50.18

2.7

2.2

3.2

2.9

mg/l

3.41

772

4551

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1820

14230

1.88

48.33

3.9

3.0

60.3

47.2

u/l

5.05

1723

13101

(3015377) Calcium [Moles/volume] in Serum or Plasma

1026

6818

1.82

45.91

3.4

2.1

2.4

mmol/l

0.67

895

5697

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1015

6738

1.82

45.46

3.4

3.0

1778.3

1290.1

ng/l

1.62

897

5763

(3021447) Carbon dioxide [Partial pressure] in Venous blood

403

1967

2.24

43.45

4.5

3.6

5.8

5.9

kpa

0.38

387

1912

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

19.12

43.15

5.8

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

374

1796

2.26

41.85

7.6

6.7

1.3

1.4

mmol/l

1.74

364

1742

(3002032) Base excess in Venous blood by calculation

397

1962

2.20

41.38

4.5

3.6

1.9

2.0

mmol/l

0.23

328

1625

(3019550) Sodium [Moles/volume] in Serum or Plasma

2581

23516

4.21

41.30

26.7

14.8

139.6

139.8

mmol/l

5.95

2566

22897

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

580

3316

1.96

40.72

2.0

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

231

899

2.72

40.71

5.7

4.6

1.8

1.6

2.36

223

840

(40768800) Prostate Pathology biopsy report

133

5.77

40.55

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

577

3306

1.95

40.20

2.0

29.9

29.8

0.11

559

3200

(3023103) Potassium [Moles/volume] in Serum or Plasma

2583

23595

4.19

40.12

27.1

14.9

4.0

mmol/l

1.86

2565

22943

(3020779) Urea [Moles/volume] in Serum or Plasma

374

1826

2.22

40.10

7.0

7.5

10.4

10.1

mmol/l

0.26

350

1737

(3019060) Gas panel - Arterial blood

309

1409

2.35

38.91

5.4

4.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1271

9288

1.71

38.76

2.7

2.3

74.9

78.7

nmol/l

5.43

1170

8219

(3020682) Albumin/Creatinine [Ratio] in Urine

1119

7907

1.72

38.58

4.3

4.0

13.7

7.9

mg/mmol

2.03

776

4913

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1215

8786

1.70

38.41

4.4

3.6

90.6

50.6

ng/l

0.37

905

6082

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

757

4795

1.81

38.23

1.7

1.1

1.2

mg/l

0.65

594

3677

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1228

8928

1.70

37.87

3.4

2.8

143.4

125.7

ug/l

0.97

1139

8228

(3007930) Methemoglobin/Hemoglobin.total in Blood

223

887

2.65

37.59

5.6

4.6

0.9

0.62

215

832

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

300

1380

2.32

36.95

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

1090

7750

1.69

36.00

3.5

3.2

7.4

mmol/l

0.11

939

6510

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

276

1256

2.34

34.78

8.8

9.0

0.6

0.7

1.63

276

1246

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

276

1267

2.31

34.06

8.8

8.9

1.5

1.4

0.83

276

1260

(3017446) Testosterone [Moles/volume] in Serum or Plasma

278

1281

2.31

34.01

2.1

2.2

9.6

14.3

nmol/l

16.01

235

1125

(40768797) Stomach Pathology biopsy report

533

3127

1.88

33.93

1.3

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

274

1260

2.31

33.67

8.9

9.0

93.4

0.03

274

1255

(3027945) Reticulocytes/100 erythrocytes in Blood

426

2325

1.99

33.62

2.8

2.2

1.9

1.8

2.47

378

2036

(3017181) Myelocytes/100 leukocytes in Blood

337

1688

2.14

33.57

4.1

3.9

1.1

0.7

1.72

342

(3020630) Protein [Mass/volume] in Serum or Plasma

349

1775

2.11

33.40

2.3

1.6

65.6

67.1

g/l

2.84

315

1599

(3012516) Albumin [Mass/volume] in Urine

1050

7503

1.66

33.28

3.5

3.2

464.9

229.1

mg/l

0.87

722

4644

(3002179) Metamyelocytes/100 leukocytes in Blood

318

1562

2.18

33.28

3.8

3.7

0.9

0.5

1.54

254

(3002385) Erythrocyte distribution width [Ratio]

2127

18243

1.83

33.16

26.7

15.0

14.1

13.6

25.23

2110

17789

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

696

4456

1.76

33.11

4.6

3.8

362.9

427.6

ng/l

0.12

564

3541

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2057

17480

1.78

32.96

4.6

4.0

14.9

14.8

pmol/l

0.07

1903

15855

(3021440) Promyelocytes/100 leukocytes in Blood

323

1623

2.13

31.83

4.2

3.9

0.1

0.39

317

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

268

1253

2.27

31.60

3.2

3.0

4.4

4.5

pmol/l

1.17

236

1085

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1282

9719

1.62

31.47

2.3

2.0

91.3

95.6

pmol/l

2.51

708

4914

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2384

21329

2.13

31.40

20.7

11.4

79.0

78.4

ml/min/173m2

0.78

2132

17189

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1019

7308

1.64

31.32

2.4

2.2

191.1

212.2

u/l

0.31

974

6838

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

190

765

2.60

31.16

2.7

1.5

35.5

27.7

u/ml

0.45

183

726

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

336

1742

2.06

30.41

4.1

3.8

99.9

92.9

ng/l

0.66

299

1491

(3026493) Urate [Moles/volume] in Serum or Plasma

868

6020

1.66

30.21

2.8

2.4

6746.4

5171.3

umol/l

0.39

755

5178

(3024354) Oxygen [Partial pressure] in Venous blood

320

1639

2.08

29.91

4.0

2.9

4.8

4.5

kpa

1.24

308

1587

(3044889) 12 lead EKG panel

1931

16295

1.67

29.74

4.5

3.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

326

1690

2.06

29.47

3.9

3.0

1.2

mmol/l

0.02

306

1427

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

107

323

3.41

29.34

1.3

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2343

20944

1.99

29.18

5.6

4.8

1.9

2.0

mu/l

1.63

2172

19079

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2581

24040

3.42

29.10

27.1

14.4

80.4

77.5

umol/l

2.51

2581

24033

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

212

935

2.38

28.56

1.6

1.5

1.7

1.5

g/l

2.61

184

809

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

261

1261

2.19

28.31

4.5

3.3

2.4

1.8

mmol/l

1.89

208

931

(3022145) Colonoscopy Study observation

406

2310

1.89

27.97

1.4

1.3

—

(3009343) pH of Capillary blood

267

1312

2.15

27.74

4.7

3.4

7.4

0.03

153

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

270

1334

2.14

27.66

4.8

3.4

5.4

5.2

kpa

2.56

256

1233

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

257

3.63

27.62

2.8

1.9

1538.5

70.8

u/ml

0.55

229

(3025159) Blasts/100 leukocytes in Blood

302

1558

2.06

27.59

4.3

4.0

0.2

0.4

0.17

277

(3009261) Glucose [Presence] in Urine by Test strip

1387

10935

1.56

27.25

4.0

3.6

0.0

estimate

1.08

296

1781

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

360

3.17

27.11

1.4

1.5

—

(40761511) CBC panel - Blood by Automated count

2515

23216

2.51

27.02

21.1

12.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

241

1156

2.19

26.58

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

782

5433

1.62

26.29

1.7

1.5

20.7

20.9

nmol/l

0.10

687

4582

(3021601) Nitrite [Presence] in Urine by Test strip

1369

10820

1.55

26.17

5.6

4.8

0.0

estimate

0.80

317

1838

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

402

2329

1.86

26.04

1.9

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

631

2.58

25.81

2.3

2.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

214

991

2.26

25.70

5.0

4.1

23.9

24.3

mmol/l

0.63

202

877

(3004588) Protein electrophoresis panel - Serum or Plasma

295

1550

2.02

25.55

2.3

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

399

2327

1.84

25.26

1.9

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

411

2420

1.83

25.22

1.9

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

266

1357

2.07

24.97

8.3

6.6

25.5

24.6

mmol/l

3.61

255

1255

(3049717) Cytology report of Urine Cyto stain

161

674

2.48

24.29

3.6

1.8

—

(40768795) Lymph node Pathology biopsy report

7.64

24.21

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

319

1762

1.92

23.84

2.7

2.2

74.8

69.1

e9/l

2.04

242

1327

(3039000) Anion gap in Blood

125

472

2.73

23.26

7.6

6.4

10.8

11.2

mmol/l

0.63

117

419

(3018572) Chloride [Moles/volume] in Blood

125

472

2.73

23.26

7.6

6.4

104.8

105.0

mmol/l

0.18

117

419

(3035350) Ketones [Presence] in Urine by Test strip

1348

10795

1.50

23.04

3.9

3.6

0.0

estimate

0.00

304

1815

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2375

21660

1.89

23.01

7.9

6.1

42.0

40.2

mmol/mol

17.41

2246

20062

(46235355) HIV 1 and 2 tests - Meaningful Use set

409

2470

1.77

22.91

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

145

601

2.49

22.35

3.6

3.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

260

1371

1.99

22.20

3.9

3.0

126.6

130.9

g/l

2.16

249

1329

(3017143) Hepatitis C virus Ab [Presence] in Serum

326

1856

1.86

22.13

1.6

—

(3047181) Lactate [Moles/volume] in Blood

156

672

2.40

22.11

7.7

5.7

1.2

1.3

mmol/l

0.19

143

585

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

143

594

2.49

21.94

2.9

3.3

0.4

u/ml

0.43

344

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

154

667

2.39

21.57

3.1

1.6

38.6

43.8

mg/l

0.23

121

544

(3034860) Kappa light chains.free [Mass/volume] in Serum

154

669

2.38

21.42

3.1

1.6

55.8

46.6

mg/l

0.37

122

546

(40760888) Immunoglobulin light chains.free panel - Serum

120

465

2.66

21.24

2.9

1.5

—

(3037756) Immunofixation for Serum or Plasma

103

371

2.85

20.97

1.7

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

362

2166

1.78

20.81

3.2

3.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

340

2001

1.80

20.66

3.1

3.0

234.9

184.8

ng/l

1.17

322

1837

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

194

3.57

20.39

1.2

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

17.10

20.29

1.0

3.1

4.4

nmol/l

—

(3042631) Mycobacterium sp identified in Specimen

229

3.34

20.26

2.5

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

230

3.33

20.12

3.3

1.4

1.2

0.20

164

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.01

20.03

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

147

645

2.35

20.00

3.1

1.5

1.2

2.5

ratio

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2551

24056

2.45

19.82

14.2

9.2

27.4

25.9

u/l

2.26

2507

23077

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

232

1225

1.98

19.69

1.8

1.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

467

3039

1.65

19.66

24.3

26.7

1.4

inr

0.03

433

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

342

2046

1.77

19.61

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

163

758

2.23

19.34

2.1

1.8

2.4

1.6

ug/l

0.47

144

665

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

896

2.12

19.08

2.1

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

897

2.12

19.02

2.1

1.4

7.5

7.4

g/l

0.32

125

674

(3021387) Prolactin [Units/volume] in Serum or Plasma

116

468

2.55

18.94

2.6

1.8

295.7

323.4

mu/l

0.49

107

425

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1501

12558

1.45

18.84

2.7

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

556

3813

1.58

18.78

3.0

2.1

2.5

2.4

mmol/l

3.38

491

3275

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

897

2.10

18.65

2.1

1.4

3.7

3.8

g/l

0.60

124

648

(3003694) ABO and Rh group [Type] in Blood

718

5218

1.51

18.62

1.4

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

125

528

2.43

18.52

4.3

3.0

26.0

25.2

mmol/l

1.30

110

461

(3007164) IgA [Mass/volume] in Serum or Plasma

569

3947

1.56

18.22

1.4

1.3

2.5

g/l

0.04

335

2318

(40768793) Breast Pathology biopsy report

147

3.80

18.16

1.4

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

839

2.12

18.10

2.1

1.4

9.8

10.4

g/l

1.02

142

707

(3000570) Elastase.pancreatic [Mass/mass] in Stool

138

616

2.31

18.06

1.6

1.4

233.6

297.1

ug/g

3.08

356

(3022313) Gas panel - Capillary blood

191

971

2.04

18.01

5.0

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

756

5605

1.49

17.62

4.0

3.2

—

(3013512) EKG study

883

6750

1.46

17.60

4.7

4.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

258

1466

1.84

17.49

2.2

2.3

9.8

10.7

g/l

3.01

239

1337

(3027273) Bicarbonate [Moles/volume] in Venous blood

201

1052

1.99

17.47

3.9

3.0

25.4

mmol/l

0.02

194

1017

(3037121) Protein [Mass/volume] in Urine

144

666

2.23

17.32

2.4

2.6

0.4

0.3

g/l

0.39

205

(3024928) Oxygen saturation in Venous blood

114

477

2.45

17.25

3.9

3.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

159

769

2.14

17.11

2.6

2.3

508.9

841.5

ug/l

0.50

154

719

(3000492) Spirometry study

335

2076

1.70

16.83

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

4.69

16.58

5.1

1.1

267.2

67.1

u/ml

0.53

(3042111) Morphology [Interpretation] in Bone marrow Narrative

263

2.91

16.09

1.8

1.4

—

(3007461) Platelets [#/volume] in Blood

2595

24865

2.73

15.83

33.1

18.4

257.6

249.6

e9/l

7.54

2556

24142

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2417

22592

1.76

15.73

5.6

4.8

6.3

6.0

mmol/l

20.45

2236

20603

(3024731) MCV [Entitic volume]

2595

24871

2.72

15.71

32.9

18.3

91.2

91.3

0.33

2583

24457

(3035941) MCH [Entitic mass]

2595

24874

2.72

15.65

32.9

18.3

30.2

30.4

5.48

2583

24460

(3028626) Oxygen [Partial pressure] in Capillary blood

105

443

2.43

15.63

3.7

2.7

7.9

8.0

kpa

0.38

100

405

(3026361) Erythrocytes [#/volume] in Blood

2595

24876

2.72

15.61

33.0

18.4

4.5

e12/l

4.68

2547

24054

(3010813) Leukocytes [#/volume] in Blood

2595

24880

2.71

15.53

33.1

18.4

7.4

6.6

e9/l

28.67

2547

24059

(3000963) Hemoglobin [Mass/volume] in Blood

2595

24881

2.71

15.51

33.3

18.5

133.6

136.6

g/l

18.41

2582

24469

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

841

2.03

15.45

2.1

1.4

3.2

3.0

g/l

1.34

126

662

(1616796) Gas panel - Central venous blood

101

425

2.43

15.13

3.8

3.5

—

(3021901) Oxygen saturation in Capillary blood

376

2.50

14.68

3.4

2.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

149

748

2.05

14.55

2.2

1.5

0.5

g/l

0.11

125

645

(3010421) pH of Blood

113

510

2.27

14.45

3.5

3.8

7.4

0.39

417

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

118

543

2.23

14.40

1.5

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

332

2.58

14.37

1.3

—

(4010399)

277

1701

1.70

14.31

1.5

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

625

4622

1.46

14.27

4.7

4.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

205

1158

1.83

14.13

1.6

1.4

1.1

1.2

g/l

0.32

181

1056

(3019309) Folate [Moles/volume] in Red Blood Cells

591

4337

1.47

14.01

1.9

1.7

1100.6

1169.0

nmol/l

1.06

466

3255

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

625

4645

1.45

13.85

1.3

0.9

1.8

u/ml

3.72

156

1258

(40768806) Pleura Pathology biopsy report

132

3.53

13.76

1.8

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

141

711

2.04

13.61

1.9

1.4

36.5

38.0

g/l

1.63

115

602

(3030981) Hyaline casts [#/volume] in Urine by Automated count

191

1068

1.85

13.60

3.0

2.5

0.3

0.2

e6/l

0.35

191

1036

(3012501) Base excess in Blood by calculation

421

2.35

13.59

3.4

4.1

2.6

mmol/l

0.02

282

(3008757) Leukocyte morphology finding [Identifier] in Blood

159

3.25

13.42

3.4

3.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

134

667

2.06

13.40

2.0

1.4

0.0

g/l

0.83

120

611

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

176

3.11

13.21

1.8

1.7

862.8

778.3

u/ml

0.03

170

(40768441) Liver Pathology biopsy report

103

3.83

13.16

1.0

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

434

2.31

13.12

1.9

2.8

30.4

36.2

umol/l

1.32

375

(3037522) Nuclear Ab [Titer] in Serum

442

3098

1.51

13.07

1.3

564.2

569.6

titre

0.02

676

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

113

533

2.17

13.00

1.9

2.5

4.0

3.6

g/l

2.21

107

508

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

28.50

12.95

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

104

484

2.20

12.39

1.3

1.7

1.0

0.8

nmol/l

1.63

395

(3003181) Sodium [Moles/volume] in Urine

378

2.35

12.19

1.5

1.3

60.6

61.4

mmol/l

0.06

309

(3009542) Hematocrit [Volume Fraction] of Blood

2162

19953

1.44

12.03

24.2

13.8

39.0

39.8

3.39

1477

13697

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

123

619

2.03

11.97

2.0

1.4

0.0

g/l

0.00

109

572

(3048689) Calprotectin [Mass/mass] in Stool

367

2525

1.53

11.77

2.2

157.5

142.0

ug/g

0.33

284

1997

(1761482) Bacteria [#/volume] in Urine by Culture

112

548

2.09

11.76

4.6

4.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

12.05

11.74

1.0

64.2

103.2

pmol/l

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

462

2.19

11.73

2.1

2.0

133.8

131.2

g/l

0.43

345

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

627

2.01

11.56

2.0

1.4

0.0

g/l

0.00

109

573

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

407

2.25

11.51

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

407

2.25

11.51

1.3

—

(4281824)

128

3.32

11.50

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

348

2385

1.53

11.35

1.8

1.6

1.5

0.66

291

2077

(3017354) Segmented neutrophils/100 leukocytes in Blood

160

3.04

11.35

2.8

3.1

64.3

56.3

0.98

(3000494) Fungus identified in Specimen by Culture

376

2620

1.51

11.34

1.6

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

396

2.24

10.97

2.8

2.9

—

(3008295) Osmolality of Serum or Plasma

214

2.70

10.87

1.2

1.4

277.3

276.5

mosm/kgh2o

0.08

164

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

107

533

2.05

10.73

2.1

2.3

186.4

189.4

0.12

100

505

(3021879) Hepatitis B virus core Ab [Presence] in Serum

189

1134

1.72

10.61

1.4

—

(3045142) Bone marrow Pathology biopsy report

156

2.98

10.58

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

116

3.31

10.40

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

139

769

1.85

10.27

2.0

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

209

2.67

10.27

1.3

1.1

49.4

55.0

u/l

0.64

141

(40761536) Microorganisms panel - Urine sediment

257

1692

1.57

10.00

4.5

3.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

135

3.07

9.93

1.3

271.0

279.0

u/l

0.05

129

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

145

826

1.80

9.76

2.2

1.7

—

(3017569) Oxygen content in Arterial blood

116

3.22

9.72

2.2

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

159

933

1.75

9.68

2.0

1.9

38.2

38.9

u/l

0.16

139

808

(3019225) pH of Specimen

316

2196

1.50

9.60

5.7

3.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

199

2.65

9.60

1.8

1.5

32.5

29.1

g/l

0.94

175

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2453

23429

1.60

9.58

5.8

5.3

2.6

2.7

mmol/l

13.33

2266

21611

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.81

9.50

2.8

2.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

371

2.16

9.28

1.5

1.3

10.8

9.9

u/l

0.25

303

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

194

1216

1.64

9.25

2.7

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

992

8351

1.30

9.24

4.4

3.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

407

2.10

9.12

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

416

2.08

8.99

2.4

2.3

17.1

16.5

0.83

221

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.51

8.97

1.8

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

117

3.11

8.94

1.3

1.2

20.6

18.2

u/l

0.14

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

119

656

1.85

8.93

1.4

1.6

0.3

0.2

g/l

1.65

106

622

(3003327) Ova and parasites identified in Stool by Light microscopy

117

642

1.86

8.91

1.7

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

123

3.04

8.85

1.3

1.1

84.5

82.5

u/l

0.05

106

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

109

590

1.88

8.67

1.8

2.1

95.8

91.7

1.25

104

558

(3044242) Glucose [Moles/volume] in Arterial blood

115

3.07

8.55

1.9

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

425

2.03

8.51

1.2

1.4

—

(3036489) Thrombin time

129

742

1.78

8.44

1.9

20.5

21.1

0.87

109

647

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

119

669

1.82

8.41

1.3

1.6

1.2

g/l

1.27

106

632

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.18

8.40

1.2

2.8

11.3

ug/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

103

556

1.89

8.28

1.2

66.0

90.4

titre

—

(36660697) Celiac disease serology panel - Serum

248

1690

1.52

8.26

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

2.15

8.09

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

100

540

1.89

8.03

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

521

1.89

7.93

1.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.19

7.92

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

244

2.32

7.92

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

626

5042

1.32

7.85

1.7

10325483.2

43166415.8

pmol/l

1.71

523

4163

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

400

2.00

7.67

1.4

—

(3011288) Drugs identified in Urine by Screen method

248

2.29

7.64

3.1

2.6

—

(3025941) Bacteria identified in Stool by Culture

175

1130

1.59

7.43

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

351

2.05

7.37

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

299

2.13

7.28

1.1

—

(21494434) Karyotype in Bone marrow

162

2.55

7.18

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

282

2.15

7.12

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

182

2.44

7.01

1.8

1.5

1146.9

2709.2

e6/l

1.06

129

(3033705) Calcium.ionized [Moles/volume] in Venous blood

253

2.20

6.89

2.6

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.09

6.74

2.8

2.0

10.7

13.9

0.71

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.40

6.69

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.40

6.69

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.40

6.69

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.40

6.69

1.5

—

(3023419) Bacteria identified in Sputum by Culture

290

2.09

6.65

2.8

2.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2396

23012

1.41

6.56

5.1

4.7

4.5

4.7

mmol/l

18.77

2229

21332

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

113

675

1.70

6.55

1.4

1.6

0.1

4.8

iu/ml

0.50

132

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2381

22846

1.40

6.53

5.1

4.7

1.4

1.5

mmol/l

38.09

2197

21041

(3035880) pH of Pleural fluid

3.04

6.34

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

699

5855

1.26

6.26

4.3

4.0

0.0

estimate

0.69

300

1810

(3014765) Yersinia sp identified in Stool by Organism specific culture

105

623

1.71

6.25

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

220

1552

1.46

6.20

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.67

6.19

3.9

2.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.07

6.19

2.8

2.1

—

(3011412) CD3 cells [#/volume] in Blood

122

2.64

6.06

3.1

2.1

0.9

1.1

e9/l

0.42

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

122

2.64

6.06

1.4

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

553

1.74

6.06

2.1

2.0

12.0

11.3

mg/l

0.28

503

(3028308) Erythrocytes [#/volume] in Pleural fluid

160

2.39

5.88

1.8

1.6

11908.7

84791.7

e6/l

1.11

(42529406) Shigella sp [Presence] in Stool by Culture

104

628

1.68

5.83

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

103

621

1.69

5.80

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.52

5.80

1.0

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.88

5.78

4.3

4.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

121

762

1.62

5.76

4.2

3.8

1.3

1.4

mmol/l

0.45

121

749

(3012441) Differential panel - Pleural fluid

157

2.38

5.64

1.8

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

768

6567

1.24

5.63

1.8

1.7

1.5

1.4

mmol/l

5.71

649

5502

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

395

1.85

5.61

1.3

1.2

29.4

20.6

u/l

0.48

347

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

525

4307

1.27

5.52

3.2

2.7

0.8

0.7

ug/l

0.48

385

2876

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2305

22104

1.32

5.51

4.6

4.2

1.5

1.3

mmol/l

22.21

2116

20171

(3011397) Hemoglobin [Presence] in Urine by Test strip

634

5326

1.25

5.43

3.5

3.7

—

(3028707) Methadone [Presence] in Urine by Screen method

179

2.25

5.42

1.5

2.2

—

(3044927) Protein electrophoresis panel - Urine

259

2.03

5.39

1.3

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

199

2.18

5.38

1.2

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

2.56

5.37

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

168

2.28

5.30

3.6

2.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

125

2.50

5.28

1.7

1.5

5.2

7.2

u/l

0.33

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

812

1.57

5.25

1.7

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

262

2.00

5.23

6.9

7.0

11.9

12.0

mg/l

0.05

242

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

290

1.95

5.22

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

540

1.69

5.20

2.0

1.9

4.4

4.5

iu/l

0.04

186

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

869

7580

1.22

5.18

5.5

3.8

2.3

2.4

ug/l

0.16

800

6834

(3004451) EKG impression Narrative

109

2.59

5.13

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

266

1.97

5.03

2.1

1.9

3438.1

1490.8

u/l

0.25

106

(3043410) Blood group antigens tested for on Red Blood Cells

3.42

5.02

2.7

1.3

—

(40765096) Chromosome analysis panel by Banding

3.90

4.98

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

404

1.78

4.96

2.1

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.87

4.92

1.2

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

494

4078

1.26

4.89

1.3

33.1

35.4

iu/ml

0.16

174

1285

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

214

2.07

4.89

3.0

3.9

—

(3017732) Neutrophils [#/volume] in Blood

201

1460

1.41

4.87

3.5

2.8

4.5

4.1

e9/l

1.38

154

1092

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

355

1.82

4.86

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

107

2.54

4.79

1.1

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

144

2.31

4.77

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

144

2.31

4.77

1.6

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

144

2.31

4.77

1.6

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.89

4.76

1.3

1.5

0.4

ug/l

0.25

(3051611) Lipemic interference index of Serum or Plasma

203

2.09

4.75

4.0

3.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.28

4.74

1.7

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.28

4.74

1.7

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.28

4.74

1.7

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

388

1.77

4.72

1.5

1.9

—

(3027008) Opiates [Presence] in Urine

388

1.77

4.72

1.5

1.9

—

(3000330) Specific gravity of Urine by Test strip

165

1164

1.45

4.70

4.4

3.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1827

1.36

4.64

3.2

2.3

67.9

65.5

ml/min/173m2

0.17

113

703

(3016879) Cocaine [Presence] in Urine

361

1.79

4.62

1.5

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.76

4.61

1.7

3.0

87.5

202.0

umol/l

1.40

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

304

1.86

4.58

1.1

—

(3028300) Cannabinoids [Presence] in Urine

392

1.75

4.57

1.5

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

475

1.68

4.57

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

506

1.66

4.56

2.7

2.8

1.6

mg/l

0.00

458

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

269

1.91

4.55

1.0

1.1

1.6

1.5

g/l

0.60

230

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

327

1.82

4.52

1.2

282.8

263.5

u/ml

0.17

201

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.06

4.51

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

313

1.84

4.50

1.3

1.5

125.4

111.3

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

161

2.19

4.49

1.6

1.3

0.3

nmol/l

0.34

127

(21494814) CD8 cells/100 lymphocytes in Specimen

3.42

4.46

4.0

2.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.42

4.46

1.7

1.4

3.1

3.2

0.02

(3045788) Cell count panel - Pleural fluid

149

2.23

4.43

1.8

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

182

2.10

4.42

1.2

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

573

1.61

4.41

1.3

1.2

550.7

494.2

mg/l

0.61

535

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

106

2.47

4.38

1.1

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

353

1.77

4.36

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

361

1.76

4.34

1.0

1.1

2493.0

88.6

iu/ml

0.46

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

260

1.90

4.31

2.3

26.9

22.5

mg/l

0.21

(3019977) pH of Arterial blood

107

2.44

4.30

3.2

2.2

7.4

0.65

(3023511) Choriogonadotropin [Units/volume] in Urine

152

2.19

4.24

1.6

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

307

2433

1.30

4.21

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

1.89

4.17

1.3

—

(44790047)

208

1.99

4.12

1.4

—

(44790049)

208

1.99

4.12

1.4

—

(44790048)

208

1.99

4.12

1.4

—

(44806118)

208

1.99

4.12

1.4

—

(4268621)

222

1.95

4.11

2.7

2.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

633

1.55

4.07

1.4

1.3

33.1

33.4

iu/l

0.03

551

(3051651) Icteric interference index of Serum or Plasma

110

2.38

4.07

4.4

3.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

303

1.80

4.01

1.5

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

702

6124

1.20

4.00

4.6

3.7

20.8

24.0

6.58

378

2906

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

581

1.57

3.97

1.1

18.2

5.2

u/ml

0.48

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

2.27

3.96

1.8

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.54

3.96

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.54

3.96

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

177

2.05

3.95

2.3

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

113

2.31

3.85

1.1

—

(3020891) Body temperature

126

882

1.45

3.80

5.6

4.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

508

1.59

3.79

1.3

6.9

27.9

e6/l

1.03

397

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

508

1.59

3.79

1.3

1.4

3128.5

1152.8

e6/l

0.55

418

(3026389) Candida sp identified in Specimen by Organism specific culture

280

1.80

3.76

1.6

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

462

3892

1.23

3.76

1.3

1.2

10.9

12.7

u/ml

0.20

156

1494

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

188

1.98

3.73

1.8

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

303

1.76

3.73

1.1

1.2

125.1

116.4

1.20

273

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

333

1.73

3.72

1.4

1.2

1.6

3.2

u/ml

1.03

110

(1002224) Polysomnography panel

127

895

1.44

3.70

1.0

1.1

—

(3014891) Appearance of Pleural fluid

4.01

3.70

2.1

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

624

1.52

3.68

2.0

2.3

232.0

84.0

ug/min

0.76

380

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

169

2.02

3.64

1.8

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

343

1.71

3.63

1.4

1.7

0.5

0.9

g/l

4.72

264

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

254

1.83

3.63

1.7

1.4

—

(40768443) Skin Pathology biopsy report

126

892

1.43

3.59

1.2

—

(3045424) Erythrocytes [Presence] in Urine

375

1.67

3.58

1.4

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

508

1.57

3.57

1.3

1.2

4.0

3.9

mmol/l

0.36

470

(3005322) IgE [Units/volume] in Serum or Plasma

178

1339

1.35

3.55

1.2

1.3

156.6

189.3

u/ml

0.41

164

1228

(3044290) Cell count panel - Cerebral spinal fluid

454

1.60

3.54

1.2

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

462

1.60

3.53

1.5

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

192

1.94

3.53

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.17

3.50

1.6

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

10.02

3.49

1.2

1.7

1.2

2.1

nmol/l

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.34

3.47

4.3

2.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

310

1.72

3.47

1.1

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.90

3.46

1.1

1.0

97.8

93.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.90

3.46

1.1

1.0

89.7

90.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

166

2.00

3.44

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

180

1.96

3.43

1.8

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

141

1028

1.39

3.42

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

135

977

1.40

3.42

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

319

1.71

3.42

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.35

3.41

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.35

3.41

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

2.25

3.38

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

120

2.18

3.38

1.3

137.7

143.5

nmol/l

0.22

120

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.11

3.37

1.2

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

437

1.59

3.35

3.6

3.1

0.8

nmol/l

0.06

337

(3000285) Sodium [Moles/volume] in Blood

3.45

3.33

1.4

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

240

1.80

3.31

1.7

1.4

—

(21494755) Public health laboratory ask at order entry panel

119

1644

0.71

3.31

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

241

1.80

3.27

1.7

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

2.21

3.25

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

227

1.82

3.24

1.5

1.8

—

1840.0

—

(3027944) Amphetamines [Presence] in Urine

386

1.62

3.24

1.5

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

243

1.78

3.19

1.7

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

104

2.22

3.15

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

265

2141

1.26

3.15

2.6

2.4

6.7

7.7

ug/l

0.29

235

1896

(3014271) Vancomycin [Susceptibility]

111

2.17

3.12

2.5

3.0

—

(4306422)

321

1.66

3.09

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

2.20

3.09

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

363

3046

1.22

3.07

1.5

1.4

—

(3017704) Immunofixation for Urine

112

2.15

3.06

2.5

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.46

3.04

2.0

2.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

2.11

3.04

1.4

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.27

3.03

2.2

2.0

893.6

429.8

e6/l

1.03

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.90

3.02

1.3

1.5

—

(40758292) HTLV I+II Ab panel - Serum

5.85

3.02

1.3

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

309

1.66

2.98

1.5

56.3

60.9

0.32

193

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.24

2.96

1.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

155

1.95

2.94

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

177

1372

1.31

2.92

1.2

192.0

151.4

iu/ml

0.43

536

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

250

1.73

2.92

1.7

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.26

2.86

2.3

2.0

0.3

0.2

e9/l

1.03

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.45

2.79

1.0

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

1.90

2.75

2.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

203

1.78

2.73

2.9

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.60

2.70

1.1

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

6.01

2.70

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

125

934

1.35

2.67

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

250

1.69

2.65

1.8

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

183

1.81

2.65

1.2

—

104.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

162

1.86

2.62

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

162

1.86

2.62

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

1.98

2.60

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

674

1.41

2.59

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

163

1.85

2.57

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

114

2.03

2.56

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

550

1.45

2.55

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

323

1.59

2.55

1.4

1.2

5.4

4.8

u/ml

0.06

136

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.15

2.55

1.4

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

108

2.05

2.51

1.1

121.2

88.9

u/l

0.43

(3016018) Differential panel - Cerebral spinal fluid

224

1.71

2.50

1.2

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

165

1.83

2.49

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

165

1.83

2.49

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

165

1.83

2.49

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.47

2.48

2.7

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.20

2.47

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

109

2.03

2.46

1.1

47.7

26.1

u/l

0.37

(3034426) Prothrombin time (PT)

2.24

2.44

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

112

837

1.35

2.42

1.1

—

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

175

1.78

2.38

1.0

—

(3011648) Oxygen content in Venous blood

183

1.76

2.35

1.6

2.2

10.9

11.0

0.07

183

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1167

0.72

2.35

1.4

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

229

1.67

2.33

1.5

1.4

36.3

31.4

0.33

144

(3021788) Differential panel - Synovial fluid

445

1.47

2.32

1.7

1.4

—

(4146454)

276

1.60

2.31

2.8

—

(3023410) Appearance of Cerebral spinal fluid

215

1.68

2.29

1.4

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

185

1.74

2.28

1.1

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

657

1.38

2.27

5.0

4.1

3.8

3.9

mmol/l

0.59

623

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

1.99

2.25

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

441

0.56

2.21

1.4

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

197

1.68

2.12

1.3

1.4

25.3

30.2

u/l

0.38

147

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

123

1.88

2.11

2.3

2.0

21.5

151.9

ug/min

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

205

1.67

2.11

1.1

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

464

1.43

2.08

1.2

14.1

44.7

u/ml

—

(3047189) Immunofixation for 24 hour Urine

2.14

2.08

2.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

245

1.60

2.07

1.3

—

(3042517) Benzodiazepines panel - Urine

5.01

2.07

2.4

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.01

2.07

1.0

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

120

930

1.30

2.07

1.3

1.2

0.3

1.2

u/ml

—

(3000012) Reticulocyte production index

110

1.92

2.05

1.2

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.18

2.04

1.3

1.5

—

1497021.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

139

1740

0.79

2.03

1.9

1.8

—

(3025130) Human papilloma virus identified in Specimen

223

1.62

2.02

2.0

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

2.41

2.02

4.1

6.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.08

2.01

1.0

—

(3022689) Creatine [Moles/volume] in Urine

2.05

2.01

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

352

1.49

2.00

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

377

1.47

1.99

3.6

3.4

61.1

57.6

1.20

377

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.97

1.93

1.1

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.45

1.93

4.8

3.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

381

1.45

1.90

1.1

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

602

1.36

1.88

2.0

1.5

12314.3

11166.9

e6/l

0.12

440

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.09

1.86

1.4

1.1

1.3

3.0

ug/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

493

1.39

1.84

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

3.53

1.83

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.05

1.80

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

539

1.36

1.78

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

480

1.38

1.77

3.6

3.4

28.9

27.9

mg/l

0.07

297

(3014148) Varicella zoster virus Ab [Titer] in Serum

208

1.59

1.77

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.98

1.74

2.4

2.3

43.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

155

1.68

1.72

1.2

12.7

11.9

mmol/l

0.21

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.85

1.71

1.8

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.85

1.71

1.2

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.85

1.71

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

3.16

1.66

1.2

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.16

1.66

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.10

1.65

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.80

1.65

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

2.25

1.63

1.3

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

237

1.53

1.62

3.3

3.0

252.7

27.5

mg/l

0.89

179

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.58

1.61

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.58

1.61

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.58

1.61

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

1.61

3.6

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

1.61

3.6

2.6

—

(3009871) Measles virus Ab [Titer] in Serum

1.95

1.59

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

560

1.33

1.57

1.5

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.11

1.55

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

156

0.45

1.55

1.0

1.5

55.5

265.1

pmol/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

232

1.52

1.54

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.93

1.54

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.93

1.54

1.7

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.98

1.54

2.1

2.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

265

1.48

1.53

1.2

1.0

11.3

1.8

u/ml

1.01

111

(3025549) Creatine [Moles/time] in 24 hour Urine

2.86

1.50

1.8

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.23

1.46

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

1.77

1.44

2.1

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.04

1.43

1.1

—

(3004775) Volume in Urine collected for unspecified duration

196

1.54

1.43

2.0

2.3

767.0

622.9

0.98

127

(3020491) Glucose [Moles/volume] in Blood

165

1.58

1.40

2.0

6.7

6.6

mmol/l

0.03

105

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

599

1.29

1.38

1.3

1.2

12.5

5.1

u/ml

0.32

101

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

1.74

1.37

1.4

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.61

1.36

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.94

1.36

1.2

—

(3045414) Leukocytes [Presence] in Urine

125

1034

1.22

1.34

1.8

1.9

—

(3048879) Bone marrow aspiration report

2.13

1.33

2.8

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.97

1.32

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.36

1.29

1.1

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.78

1.28

2.8

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

130

1086

1.21

1.27

1.7

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

2.05

1.26

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

590

1.28

1.26

1.3

1.2

2.4

2.9

u/ml

0.27

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

171

1.53

1.23

3.3

2.0

0.9

2.2

u/field

—

(3032057) Clostridioides difficile [Presence] in Stool

2.04

1.22

2.2

2.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

116

1.64

1.21

12.1

11.9

799.4

835.8

nmol/l

0.13

109

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

383

1.34

1.20

1.2

1.4

—

(40768446) Kidney Pathology biopsy report

1.75

1.19

1.5

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.31

1.18

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

109

1.66

1.18

1.1

1.2

—

(4034850)

826

0.78

1.18

9.3

9.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.88

1.18

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

165

1.52

1.17

1.2

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

1.16

0.0

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.15

1.6

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.50

1.15

1.8

1.4

—

5.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.90

1.12

1.1

—

(1761868) Lipid panel - Serum or Plasma

824

7798

1.08

1.11

3.3

3.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.78

1.10

1.3

1.4

9.0

8.9

ug/l

0.05

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.26

1.10

14.9

9.8

5.7

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.26

1.10

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

143

1225

1.18

1.09

1.8

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.19

1.08

1.0

1.4

—

(4062490)

219

1.42

1.07

1.2

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.93

1.06

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

137

1.54

1.05

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

446

1.28

1.04

1.5

1.6

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.96

1.03

1.2

2.0

1.2

mmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.84

1.02

1.1

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

221

1.41

1.02

1.2

1.4

2.9

g/l

0.02

158

(3027135) IgG subclass 1 [Mass/volume] in Serum

221

1.41

1.02

1.2

1.4

6.7

6.8

g/l

0.03

160

(3024139) IgG subclass 3 [Mass/volume] in Serum

221

1.41

1.02

1.2

1.4

0.3

0.4

g/l

1.78

159

(3001019) Free T4 and TSH panel - Serum or Plasma

961

0.82

1.01

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.88

1.00

1.2

1.5

149.4

124.0

ng/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

164

1.47

0.99

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

164

1.47

0.99

1.0

1.4

1.6

1.3

promille

0.33

128

(44806420)

1.71

0.99

2.2

2.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.67

0.97

1.1

1234.9

1708.0

miu/ml

0.69

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

225

1.38

0.94

1.0

1.1

—

21.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.22

0.93

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

652

0.79

0.90

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

280

1.33

0.88

1.2

1.3

7.4

7.7

mmol/l

0.24

209

(3006270) Folate [Moles/volume] in Blood

212

1.37

0.86

1.1

1.2

305.0

382.8

nmol/l

0.95

186

(3010144) Erythrocytes [#/volume] in Synovial fluid

230

1.35

0.84

1.4

1.3

194071.7

138168.4

e6/l

0.12

160

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.78

0.84

3.8

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.76

0.83

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.76

0.83

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

163

1.41

0.82

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.65

0.81

5.9

6.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

138

1.45

0.81

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.79

0.0

1.4

—

7.9

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

1.45

0.78

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

1.45

0.78

1.4

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

148

1.42

0.77

3.0

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

100

0.50

0.77

1.0

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

107

1.50

0.76

1.4

1.7

2.2

2.0

u/field

0.08

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.70

0.75

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

306

1.28

0.75

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.2

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

406

1.24

0.73

2.1

1.4

—

(3002619) Bacteria identified in Specimen by Culture

1.80

0.72

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.62

0.71

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

291

1.28

0.71

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

1.25

0.70

1.5

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

118

1.44

0.69

1.2

1.0

—

(4198724)

1.64

0.68

1.1

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.68

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.63

0.66

1.0

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

725

1.16

0.66

1.4

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

439

1.21

0.66

1.2

1.3

179.8

209.8

miu/ml

0.27

195

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.51

0.66

1.5

1.8

19.3

109.1

ug/l

0.49

(3025018) Bordetella pertussis Ab [Titer] in Serum

111

1.44

0.66

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.73

0.64

1.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

121

1.41

0.62

1.1

1.3

6.4

6.1

mmol/l

0.21

116

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

288

3086

0.93

0.61

8.3

6.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.60

0.0

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.53

0.59

1.2

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

185

0.70

0.58

1.2

1.5

1.0

g/l

0.06

185

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.46

0.58

1.0

1.1

112.6

90.7

—

(3006462) Nitrate [Presence] in Urine

106

1.42

0.57

4.1

3.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.57

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

141

1.35

0.56

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.46

0.56

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.42

0.54

3.1

1.9

734.6

753.3

e6/l

—

(4015189)

1.45

0.53

3.3

2.4

—

(3024932) HLA-DR beta [Type]

1.43

0.52

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.45

0.51

1.2

—

(3024471) HLA-A [Type]

1.39

0.50

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.39

0.50

5.6

6.6

—

(4027681)

118

1.36

0.50

1.2

—

(3028433) Virus identified in Specimen by Culture

1.49

0.49

1.6

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

111

1.35

0.46

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

1.43

0.46

2.7

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.37

0.44

4.1

6.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

202

1.24

0.43

1.0

309.6

346.1

ng/l

0.33

132

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

202

1.24

0.43

1.0

793.6

708.8

ng/l

0.30

128

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

130

0.69

0.43

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

130

0.69

0.43

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

131

0.69

0.43

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

131

0.69

0.43

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.61

0.43

1.0

1.2

—

(3008898) HLA-B27 [Presence]

698

1.12

0.42

1.0

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.56

0.42

1.0

—

(3020650) Glucose [Presence] in Urine

1.38

0.41

1.1

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

240

1.21

0.41

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

317

3017

1.06

0.41

4.9

31.2

32.8

1.66

225

2011

(3019420) Tryptase [Mass/volume] in Serum or Plasma

105

1.34

0.41

1.1

1.7

5.4

9.6

ug/l

1.51

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.36

0.41

2.8

2.7

405.5

752.5

e6/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

138

0.72

0.40

1.5

—

(3019150) Specific gravity of Urine by Refractometry

512

4938

1.05

0.40

4.2

4.1

1.0

kg/l

0.48

719

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

205

1.22

0.39

1.0

36.5

48.2

ng/l

0.91

130

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.39

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(4211845)

115

1.31

0.38

4.1

3.4

—

(3042733) HLA Ab [Presence] in Serum

1.31

0.37

7.8

5.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.35

0.37

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.33

0.33

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.33

0.33

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

673

0.90

0.30

1.6

1.8

—

(3005033) Fetal Nuchal fold Thickness US

109

0.73

0.29

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

298

1.14

0.28

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

151

0.79

0.28

1.2

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.26

0.26

1.0

1.1

—

13.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.22

0.25

1.2

1.1

1.2

1.1

u/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.22

0.25

1.0

—

(4024509)

245

1.14

0.24

1.4

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

256

1.13

0.23

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

125

1.20

0.22

1.1

—

(3022621) pH of Urine by Test strip

155

1480

1.05

0.22

3.5

2.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.22

0.22

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3051593) INR in Capillary blood by Coagulation assay

117

1.20

0.20

14.9

9.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

316

1.11

0.20

1.1

—

12.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.25

0.20

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

0.80

0.20

1.3

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.22

0.20

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

114

0.79

0.20

1.6

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.19

3.0

1.7

—

(40761535) Cells panel - Urine sediment

202

1952

1.04

0.18

3.6

3.3

—

(3015183) Erythrocyte sedimentation rate

100

1.20

0.18

1.4

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.71

0.16

1.6

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.13

0.16

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

235

0.89

0.16

1.6

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

168

1.13

0.15

1.3

0.5

1.0

u/ml

0.31

(3037556) Urate [Mass/volume] in Serum or Plasma

0.81

0.14

1.7

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

256

1.09

0.14

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

110

0.82

0.13

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

149

1446

1.03

0.12

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

302

3077

0.98

0.12

1.5

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.16

0.11

1.2

1.1

253.0

201.9

iu/ml

0.17

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

792

0.96

0.11

1.3

1.7

4.9

3.7

mg/l

0.26

544

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.14

0.10

1.0

1.2

—

(4133840)

1.11

0.09

1.8

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

106

1.13

0.09

1.2

1.4

17.7

20.6

umol/l

0.19

100

(3032773) Endomysium IgG Ab [Titer] in Serum

176

0.91

0.09

1.1

—

(4094501)

704

1.04

0.09

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.79

0.08

4.4

2.7

—

64.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

264

1.06

0.07

1.0

1.1

8.2

3.3

u/ml

0.36

123

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.03

0.07

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

537

0.97

0.06

2.3

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

297

1.04

0.05

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

647

1.02

0.03

1.6

1.4

—

(44813793)

141

1.06

0.03

1.3

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

260

0.96

0.03

1.0

1.1

1.8

0.8

u/ml

—

104

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

128

0.94

0.02

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

198

0.96

0.02

1.0

1.1

1.5

2.6

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

308

0.97

0.02

1.1

0.6

1.8

u/ml

—

120

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

197

0.96

0.01

1.3

1.2

—

47.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

234

1.03

0.00

1.0

1.1

0.8

1.9

u/ml

—

(3024263) Appearance of Synovial fluid

136

1.03

0.00

1.9

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

194

0.98

0.00

1.3

1.1

—

61.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

214

0.98

0.00

1.0

1.1

2.1

2.3

u/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

182

0.99

0.00

1.3

1.2

—

4.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

5.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.97

0.00

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.00

0.00

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1228.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

15.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

7.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

4.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

2.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

3.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_ADRENAL_EXALLC – Benign neoplasm: Adrenal gland

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Adrenal gland

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints